Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors
Clinical trial NCT02573272 · UNKNOWN
Trial details
- NCT number
- NCT02573272
- Sponsor
- Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-07-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.